Test Notification - Counterpart

bool(false) Test Notification - Counterpart

.notifications{--wpr-bg-35a04aba-83a4-432b-9eb6-9069de3bef5c: url('https://counterpart.org.au/wp-content/themes/breacan/img/bell.svg');}.about-navigators-button:after,.about-navigators-button:before{--wpr-bg-fa823748-9de7-4e22-9992-8f06a9b01e46: url('https://counterpart.org.au/wp-content/themes/breacan/img/dash.png');}.back-navigators-button:after,.back-navigators-button:before{--wpr-bg-d34fade5-a6dd-4a85-a435-a8b831813604: url('https://counterpart.org.au/wp-content/themes/breacan/img/dash.png');}.back{--wpr-bg-913c5022-4d69-4d3c-a1a1-af2af35248ac: url('https://counterpart.org.au/wp-content/themes/breacan/img/back-arrow.png');}li:before{--wpr-bg-cc594cd3-db44-432c-9273-414293040c08: url('https://counterpart.org.au/wp-content/themes/breacan/img/caret-black-right.png');}.panel-default>.panel-heading .panel-title>a:before{--wpr-bg-e1ac01ad-99b9-4a28-b8d3-ab0100e443b6: url('https://counterpart.org.au/wp-content/themes/breacan/img/caret-orange-down.png');}#site-wrapper:before{--wpr-bg-f4d2db3b-8fc8-47dc-bde4-ffc8aaad697a: url('https://counterpart.org.au/wp-content/themes/breacan/img/border-top.svg');}#site-wrapper:after{--wpr-bg-578916a6-bd69-4861-a89b-5cf39ce533f2: url('https://counterpart.org.au/wp-content/themes/breacan/img/border-bottom.svg');}.caret-down-white,.caret-up{--wpr-bg-b61a2484-88c5-4754-9419-037e5f9e9ecb: url('https://counterpart.org.au/wp-content/themes/breacan/img/caret-white-up.png');}.caret-down{--wpr-bg-0deaec80-40f2-4ccc-a948-660597ae69d9: url('https://counterpart.org.au/wp-content/themes/breacan/img/caret-orange-down.png');}#ytc-wrapper .ytc-thumbnails a.ytcthumb .ytcplay{--wpr-bg-ce6e9c54-09d3-496c-818e-8cc29120993a: url('https://counterpart.org.au/wp-content/plugins/youtube-channel-gallery/img/play.png');}

Test Notification cancer

Give Feedback